Results 251 to 260 of about 143,255 (299)
Some of the next articles are maybe not open access.
Molecular and Cellular Endocrinology, 2002
Plasma concentrations of the main vitamin D(3) metabolites (i.e., 25(OH)D(3), 1,25(OH)(2)D(3), and 24,25(OH)(2)D(3)) were measured in 14 weeks old large- and small-breed dogs (adult body weight 60 kg vs. 6 kg), raised under the same conditions. Levels of 25(OH)D(3) (approx. 22 microg/l) and 1,25(OH)(2)D(3) (approx. 40 ng/l) were similar in both groups,
Hazewinkel, H.A.W., Tryfonidou, M.A.
openaire +4 more sources
Plasma concentrations of the main vitamin D(3) metabolites (i.e., 25(OH)D(3), 1,25(OH)(2)D(3), and 24,25(OH)(2)D(3)) were measured in 14 weeks old large- and small-breed dogs (adult body weight 60 kg vs. 6 kg), raised under the same conditions. Levels of 25(OH)D(3) (approx. 22 microg/l) and 1,25(OH)(2)D(3) (approx. 40 ng/l) were similar in both groups,
Hazewinkel, H.A.W., Tryfonidou, M.A.
openaire +4 more sources
Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 1999
Pharmacokinetic and pharmacodynamic properties of vitamin D3 were described. Clinical aspects of application were also revealed.
openaire +1 more source
Pharmacokinetic and pharmacodynamic properties of vitamin D3 were described. Clinical aspects of application were also revealed.
openaire +1 more source
1993
Vitamin D3 ist schon vor sehr langer Zeit als therapeutisches Mittel bei der Psoriasis genutzt worden, aber dann wieder in Vergessenheit geraten. Wie so oft in der Medizin geht die erneute therapeutische Nutzung auf eine Zufallsbeobachtung zuruck. 1985 beobachteten Morimoto und Kumahara bei der Behandlung eines Osteoporosepatienten mit 1α-Hydroxy ...
openaire +1 more source
Vitamin D3 ist schon vor sehr langer Zeit als therapeutisches Mittel bei der Psoriasis genutzt worden, aber dann wieder in Vergessenheit geraten. Wie so oft in der Medizin geht die erneute therapeutische Nutzung auf eine Zufallsbeobachtung zuruck. 1985 beobachteten Morimoto und Kumahara bei der Behandlung eines Osteoporosepatienten mit 1α-Hydroxy ...
openaire +1 more source
Archives of Dermatological Research, 1992
The physiologically active metabolite of vitamin D3, 1 alpha,25-dihydroxycolicalciferol [1,25(OH)2D3, calcitriol] has achieved the status of a hormone. It is believed to mediate its effects by binding to a specific receptor which belongs to the family of nuclear receptors for glucocorticoids, estrogens, thyroxine, and retinoid acid.
openaire +2 more sources
The physiologically active metabolite of vitamin D3, 1 alpha,25-dihydroxycolicalciferol [1,25(OH)2D3, calcitriol] has achieved the status of a hormone. It is believed to mediate its effects by binding to a specific receptor which belongs to the family of nuclear receptors for glucocorticoids, estrogens, thyroxine, and retinoid acid.
openaire +2 more sources
Canadian journal of comparative medicine : Revue canadienne de medecine comparee, 1984
Plasma levels of vitamin D3 or 25-hydroxyvitamin D3 in ewes after administration of a single massive intravenous dose of vitamin D3 (2 X 10(6) IU) or 25-hydroxy vitamin D3 (5 mg) were determined at zero, one, two, three, five, ten and 20 days postinjection.
M, Hidiroglou, J E, Knipfel
openaire +1 more source
Plasma levels of vitamin D3 or 25-hydroxyvitamin D3 in ewes after administration of a single massive intravenous dose of vitamin D3 (2 X 10(6) IU) or 25-hydroxy vitamin D3 (5 mg) were determined at zero, one, two, three, five, ten and 20 days postinjection.
M, Hidiroglou, J E, Knipfel
openaire +1 more source